Heart Valve Diseases

The supplied grounding does not support a general aetiology for heart valve diseases. One review notes that cardiac amyloidosis can involve the valves through deposition of misfolded proteins, including immunoglobulin light chains and transthyretin, but this is presented as a cause of valvular involvement in that specific condition rather than a general cause of all heart valve diseases.

The disease process involves structural and functional impairment of the valve apparatus, which can affect valve opening or closing and alter cardiac hemodynamics. The grounding specifically links valvular disease to changes in stroke volume and left ventricular function, and notes that amyloid infiltration can remodel and impair valves in cardiac amyloidosis. Prosthetic valve dysfunction is also described as a recognized pathophysiologic problem in implanted valves.

The grounding does not support broad risk factors for heart valve diseases overall. For valvular disease in cardiac amyloidosis, shared risk factors with aortic stenosis are mentioned, but the specific factors are not provided in the supplied material.

Management in the supplied grounding is described at the modality level and includes diagnostic imaging, surgery, and therapy for valvular disease. Stress echocardiography is highlighted as a useful imaging tool for assessment and decision-making, and cardiac CT is described for evaluation of prosthetic valve dysfunction. In selected cases such as cardiac amyloidosis with aortic stenosis, transcatheter aortic valve replacement is mentioned as a therapeutic strategy.